ARDXArdelyx, Inc.

$3.78

The financials

Ardelyx, Inc. by the numbers

Ardelyx, Inc. (ARDX) reported revenue of $94M in Q1 2026 (quarter ended Mar 31, 2026), up 27% from the same quarter a year earlier. That came with a gross margin of 95% and net loss of $38M. For the full year FY2025, revenue was $407M (+22% year on year) and net income −$62M. Its largest product in Jun 2026 was Product IBSRELA at $86M, 70% of the disclosed total, well ahead of Product XPHOZAH at 26%.

Ardelyx, Inc. income statement, Q1 2026 against the same quarter a year earlier
Income statementQ1 2026Q1 2025Change
Revenue$94M$74M+27%
Gross profit$90M$62M+45%
Operating income−$33M−$36Mn/a
Net income−$38M−$41Mn/a
Diluted EPS−$0.15−$0.17n/a
Revenue by product, Jun 2026, as reported to the SEC
ProductRevenueShare
Product IBSRELA$86M70%
Product XPHOZAH$32M26%
Product And Service Other$2.7M2.2%
Product Supply$2.0M1.6%
Non Cash Royalty Related To Sale Of Future Royalties$676K0.5%
License$96K0.1%

Business Segments

Revenue split by product segment, from SEC XBRL filings.

Latest period: Jun 2026Total $123.6M (+29%)
License grew +380% year on yearProduct Supply -68% year on year
  • Product IBSRELA$86.2MQoQ +23%year on year +33%
  • Product XPHOZAH$31.9MQoQ +37%year on year +27%
  • Product And Service Other$2.7MQoQ +150%year on year -64%
  • Product Supply$2.0MQoQ +458%year on year -68%
  • Non Cash Royalty Related To Sale Of Future Royalties$676.0KQoQ -2.7%year on year -51%
  • License$96.0KQoQ +88%year on year +380%
Segment sum = 102% of reported consolidated revenue · Latest source: 10-Q filed 2026-08-06, SEC EDGAR